疑似恶性肝门部梗阻经皮与内镜引流的随机试验未获成功
本文比较经皮肝穿刺胆道引流(PTBD)与内镜逆行胰胆管造影(ERCP)作为恶性肝门部梗阻(MHO)所致胆汁淤积初始干预的随机对照试验。文中提及一项针对可切除肝门部胆管癌的RCT因PTBD组死亡率更高而提前终止,而多数观察性数据提示PTBD在实现完全引流方面更优。由于首选术式仍不确定,作者开展了本项比较研究。
要点
- PTBD与ERCP均为恶性肝门部梗阻的公认处理方式,但首选术式尚不明确。
- 一项针对可切除肝门部胆管癌的RCT因PTBD组死亡率更高而提前终止。
- 多数观察性数据提示PTBD在实现完全引流方面优于ERCP。
核心结论
- 由于首选术式仍不确定,作者旨在比较PTBD与ERCP作为恶性肝门部梗阻所致胆汁淤积初始干预的效果;本文标题提示该随机试验未获成功。
研究设计与样本
- 随机对照试验,比较PTBD与ERCP作为恶性肝门部梗阻所致胆汁淤积的初始干预。
主要发现
- 一项针对可切除肝门部胆管癌的RCT因PTBD组死亡率更高而提前终止。
- 多数观察性数据提示PTBD在实现完全引流方面优于ERCP。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Percutaneous transhepatic biliary drainage (PTBD) and endoscopic retrograde cholangiopancreatography (ERCP) are widely accepted but competing approaches for the management of malignant obstruction at the hilum of the liver. ERCP is favored in the United States on the basis of high success rates for non-hilar indications, the perceived safety and superior tissue sampling capability of ERCP relative to PTBD, and the avoidance of external drains that are undesirable to patients. A recent randomized controlled trial (RCT) comparing the 2 modalities in patients with resectable hilar cholangiocarcinoma was terminated prematurely because of higher mortality in the PTBD group.1 In contrast, most observational data suggest that PTBD is superior for achieving complete drainage.2-6 Because the preferred procedure remains uncertain, we aimed to compare PTBD and ERCP as the primary intervention in patients with cholestasis due to malignant hilar obstruction (MHO).
引用
- Elmunzer BJ, Smith ZL, Tarnasky P, et al. An Unsuccessful Randomized Trial of Percutaneous vs Endoscopic Drainage of Suspected Malignant Hilar Obstruction. Clin Gastroenterol Hepatol. 2020. PMID: 32454259. doi:10.1016/j.cgh.2020.05.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。